Close

News & Events

Vaccine-Pic

Request for Proposals for Modeling Population Benefit Versus Individual Risk (benefit-risk assessments) for the Tetravalent Live Attenuated Dengue Vaccine

A request for proposals for modeling population benefit versus individual risk (benefit-risk assessments) for the tetravalent live attenuated dengue vaccine developed by Takeda (TAK-003).  Please visit… Continue Reading Request for Proposals for Modeling Population Benefit Versus Individual Risk (benefit-risk assessments) for the Tetravalent Live Attenuated Dengue Vaccine